A study on intellectual capital and firm performance in biotech companies

Applied Economics Letters

Volumn 19, Issue 16, 2012, Pages 1603-1608

  Guo, Wen Chung ^a   Shiah Hou, Shin Rong ^b   Chien, Wei Jer ^b  

^a NATIONAL TAIPEI UNIVERSITY   (Taiwan)

^b YUAN ZE UNIVERSITY   (Taiwan)

Author keywords

biotech R D; firm performance; intellectual capital

Indexed keywords

BIOTECHNOLOGY; HIGH TECHNOLOGY INDUSTRY; HUMAN CAPITAL; INDUSTRIAL PERFORMANCE; INDUSTRIAL PRODUCTION; RESEARCH AND DEVELOPMENT;

UNITED STATES;

EID: 84859419147     PISSN: 13504851     EISSN: 14664291     Source Type: Journal    
DOI: 10.1080/13504851.2011.646062     Document Type: Article

References (17)

1. Ali-Yrkkö, J., Hyytinen, A. and Pajarinen, M. 2005. Does patenting increase the probability of being acquired? Evidence from cross-border and domestic acquisitions. Applied Financial Economics, 15: 1007-17.
2. Borrella, J. R. 2005. Patents and the faster introduction of new drugs in developing countries. Applied Economics Letters, 12: 379-82.
3. Deng, Z., Lev, B. and Narin, F. 1999. Science and technology as predictors of stock performance. Financial Analysts Journal, 55: 20-32.
4. Dumay, J. C. 2009. Intellectual capital measurement: a critical approach. Journal of Intellectual Capital, 10: 190-210.
5. Healy, P. 1985. The effect of bonus schemes on accounting decisions. Journal of Accounting and Economics, 7: 85-107.
6. Holthausen, R. W., Larcker, D. F. and Sloan, R. G. 1995. Annual bonus schemes and manipulation of earnings. Journal of Accounting Economics, 19: 29-74.
7. Jensen, M. C. and Meckling, W. M. 1976. Theory of the firm: managerial behavior, agency costs and ownership structure. Journal of Financial Economics, 3: 305-60.
8. Jensen, M. C. and Murphy, K. J. 1990. Performance pay and top-management incentives. Journal of Political Economy, 98: 225-64.
9. Mehran, H. 1995. Executive compensation structure, ownership, and firm performance. Journal of Financial Economics, 38: 163-84.
10. Miyazakia, H. and Aman, H. 2008. The stock market's valuation of R&D externalities. Applied Financial Economics Letters, 4: 369-73.
11. Morgan, A. G. and Poulsen, A. B. 2001. Linking pay to performance-compensation proposals in the S&P 500. Journal of Financial Economics, 62: 489-523.
12. Pukthuanthong, K. 2006. Underwriter learning about unfamiliar firms: evidence from the history of biotech IPOS. Journal of Financial Markets, 9: 366-407.
13. Stephan, P., Higgins, M. J. and Thursby, J. 2004. Capitalizing the Human Capital of University Scientists: The Case of Biotechnology IPOs, Atlanta, GA: Georgia State University.
14. Tehranian, H. and Waegelein, J. F. 1985. Market reaction to short-term executive compensation plan adoption. Journal of Accounting and Economics, 7: 131-44.
15. Yermack, D. 1995. Do corporations award CEO stock options effectively?. Journal of Financial Economics, 39: 237-26.
16. Zéghal, D. and Maaloul, A. 2010. Analysing value added as an indicator of intellectual capital and its consequences on company performance. Journal of Intellectual Capital, 11: 39-60.
17. Zucker, L. G., Darby, M. R. and Brewer, M. B. 1998. Intellectual human capital and the birth of US biotechnology enterprises. American Economic Review, 88: 290-306.